The Johor Premiere of AstraZeneca M+ Series 2026: Advancing Cardiorenal-Metabolic Care in Johor
omegakimia@yahoo.com
Posted in Drug Talk

The Johor Premiere of AstraZeneca M+ Series 2026: Advancing Cardiorenal-Metabolic Care in Johor

Last night, I had the privilege of speaking at The Johor Premiere – AstraZeneca M+ Series 2026, a scientific educational meeting that brought together healthcare professionals from across Johor to discuss the latest advances in cardiovascular, renal, and metabolic medicine. The evening focused on one important goal—delivering better outcomes for patients through earlier intervention, multidisciplinary […]

Advancing Interventional Cardiology: Johor Cardiology Conference 2026
omegakimia@yahoo.com
Posted in Conference, Slider

Advancing Interventional Cardiology: Johor Cardiology Conference 2026

Continuous medical education and the exchange of clinical experience are essential in advancing cardiovascular care. I was honoured to participate in two major cardiology events held in Johor Bahru on 27–28 June 2026—the 3rd Johor Cardiology Conference 2026 and the 2nd ANGIOCLUB Meeting 2026. These conferences brought together cardiologists, physicians, trainees, and healthcare professionals from […]

Connect With Experts: The Marathon to Achieve the Goal, Maintain Control
omegakimia@yahoo.com
Posted in Drug Talk

Connect With Experts: The Marathon to Achieve the Goal, Maintain Control

I would like to express my sincere gratitude to Servier Malaysia for the invitation to participate in the recent Connect With Experts educational meeting alongside Dr Teh Wai Bin, Consultant Paediatrician from KPJ Puteri Hospital. It was a privilege to share insights during my session, “The Marathon to Achieve the Goal, Maintain Control,” where we […]

omegakimia@yahoo.com
Posted in Uncategorized

Sybrava (siRNA): The Next Marathon in ASCVD Management

Sybrava For decades, cardiologists have focused on one goal: lowering LDL cholesterol (“bad cholesterol”) to prevent heart attacks and strokes. Yet despite high-intensity statins, ezetimibe, and lifestyle modification, many patients with Atherosclerotic Cardiovascular Disease (ASCVD) still fail to achieve guideline-recommended LDL-C targets. The question is no longer: “Should we lower LDL cholesterol?” The real question […]

Emergency Department: Winning in Every ACS Patient Starts Here
omegakimia@yahoo.com
Posted in Drug Talk

Emergency Department: Winning in Every ACS Patient Starts Here

On 29 April 2026, I had the privilege of conducting an educational session for the Emergency Department team at KPJ Johor Specialist Hospital, focusing on the management of Acute Coronary Syndrome (ACS) and the critical role of early decision-making in improving patient outcomes. The session, sponsored by AstraZeneca, highlighted a simple but important message: The […]

omegakimia@yahoo.com
Posted in KPJ Johor

Rotablation balloon uncrossable lesion

Rotablation!! “The balloon can’t cross…” Not all heart blockages are soft. Some are rock hard with calcium — so severe that even balloons and stents struggle to pass through. That’s where Rotablation comes in. A tiny high-speed diamond burr drills through the calcium to open the artery safely. From “impossible lesion” → successful stenting. Advanced […]

Sandoz JB GP Forum 2026: Are You in Control of Your Cholesterol?
omegakimia@yahoo.com
Posted in Drug Talk

Sandoz JB GP Forum 2026: Are You in Control of Your Cholesterol?

On 21st April 2026, I had the privilege of speaking at the Sandoz JB GP Forum held at Novotel Johor Bahru City Centre. The event brought together general practitioners and healthcare professionals from across Johor for an evening of practical, case-based discussions aimed at improving primary care management. My Session: Cholesterol Control in Real-World Practice […]